81.52
price up icon0.09%   0.3997
 
loading
Precedente Chiudi:
$81.92
Aprire:
$81.33
Volume 24 ore:
47,540
Relative Volume:
0.05
Capitalizzazione di mercato:
$5.70B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
13.56
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
-9.34%
1M Prestazione:
-14.49%
6M Prestazione:
-15.18%
1 anno Prestazione:
+44.99%
Intervallo 1D:
Value
$81.20
$83.82
Intervallo di 1 settimana:
Value
$81.20
$93.27
Portata 52W:
Value
$54.69
$126.89

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name
Nome
Lantheus Holdings Inc
Name
Telefono
978 671-8001
Name
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Name
Dipendente
834
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
LNTH's Discussions on Twitter

Confronta LNTH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
LNTH
Lantheus Holdings Inc
81.48 5.70B 1.50B 427.61M 423.98M 6.01
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
172.34 78.63B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.7201 44.54B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.21 42.61B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.23 18.79B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
127.73 13.55B 612.78M -86.37M -62.91M -0.87

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-18 Iniziato Goldman Buy
2024-09-03 Iniziato Redburn Atlantic Buy
2024-07-10 Reiterato JMP Securities Mkt Outperform
2023-12-18 Downgrade William Blair Outperform → Mkt Perform
2023-12-04 Iniziato TD Cowen Outperform
2023-09-29 Iniziato William Blair Outperform
2023-03-08 Iniziato JMP Securities Mkt Outperform
2022-11-30 Iniziato SVB Leerink Outperform
2022-10-13 Iniziato Mizuho Buy
2022-05-09 Iniziato B. Riley Securities Buy
2022-04-13 Iniziato Truist Buy
2021-02-01 Iniziato SVB Leerink Outperform
2020-06-29 Ripresa Jefferies Buy
2019-08-16 Aggiornamento CJS Securities Market Perform → Market Outperform
2017-11-02 Aggiornamento Wells Fargo Market Perform → Outperform
2016-11-08 Reiterato RBC Capital Mkts Outperform
2016-09-23 Ripresa Credit Suisse Neutral
2016-02-24 Reiterato RBC Capital Mkts Outperform
2015-12-11 Downgrade Credit Suisse Outperform → Neutral
2015-09-30 Downgrade Wells Fargo Outperform → Market Perform
2015-07-20 Iniziato Credit Suisse Outperform
2015-07-20 Iniziato Jefferies Buy
2015-07-20 Iniziato RBC Capital Mkts Outperform
2015-07-20 Iniziato Robert W. Baird Outperform
2015-07-20 Iniziato Wells Fargo Outperform
Mostra tutto

Lantheus Holdings Inc Borsa (LNTH) Ultime notizie

pulisher
09:03 AM

B. Riley Adjusts Lantheus Holdings Price Target to $127 From $146, Maintains Buy Rating - Marketscreener.com

09:03 AM
pulisher
08:06 AM

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time - The Manila Times

08:06 AM
pulisher
08:00 AM

Q4 Earnings Alert: Lantheus Set to Unveil Critical 2024 Performance Data - StockTitan

08:00 AM
pulisher
Feb 08, 2025

William Blair Issues Positive Estimate for Lantheus Earnings - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Lantheus Holdings validates Fair Value model with 59% return since January 2024 - Investing.com India

Feb 07, 2025
pulisher
Feb 07, 2025

Trend Tracker for (LNTH) - Stock Traders Daily

Feb 07, 2025
pulisher
Feb 06, 2025

Why Lantheus Holdings Stock Got Thrashed on Tuesday - AOL

Feb 06, 2025
pulisher
Feb 05, 2025

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting - The Bakersfield Californian

Feb 05, 2025
pulisher
Feb 05, 2025

Revolutionary Prostate Cancer Detection Breakthrough: Lantheus PYLARIFY Shows Success in Low PSA Patients - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

Blue Trust Inc. Boosts Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Here's Why You Should Add Lantheus (LNTH) to Your Portfolio - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Lantheus Holdings, Inc. (LNTH): Among the Best Low Risk High Growth Stocks To Invest In Now - Insider Monkey

Feb 04, 2025
pulisher
Feb 04, 2025

Lantheus goes Evergreen in a $250m upfront deal - BioProcess Insider

Feb 04, 2025
pulisher
Feb 04, 2025

12 Best Low Risk High Growth Stocks to Invest In - Insider Monkey

Feb 04, 2025
pulisher
Feb 04, 2025

KBC Group NV Has $264,000 Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

Janney Montgomery Scott LLC Acquires 5,753 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World

Feb 03, 2025
pulisher
Feb 03, 2025

Janney Montgomery Scott LLC Grows Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock Position Increased by Swedbank AB - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

SkyOak Wealth LLC Buys 5,000 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

Lantheus (NASDAQ:LNTH) Releases FY 2024 Earnings Guidance - MarketBeat

Jan 31, 2025
pulisher
Jan 30, 2025

LNTHLantheus Holdings, Inc Latest Stock News & Market Updates - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Appoints Dr. Morrow to Board of Directors - TipRanks

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus acquires radiopharma CDMO Evergreen for up to $1bn - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., to Board - citybiz

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member - The Manila Times

Jan 30, 2025
pulisher
Jan 30, 2025

Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Holdings, Inc. Enters Agreement to Acquire Evergreen TheragnosticsOn January 27, 2025, Lantheus Holdings, Inc. (NASDAQ: LNTH) announced that its subsidiary, Lantheus Medical Imaging, Inc., has entered into a definitive Agreement and Plan of - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

LNTH: Evergreen Acquisition Promotes Future Innovation - Research Tree

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus expands in neuro and oncology with LMI and Evergreen acquisitions - Medical Device Network

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus to acquire Evergreen Theragnostics for up to $1 billion - DOTmed

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus (LNTH) Stock Declines Amid Acquisition Announcement - GuruFocus.com

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus Holdings Inc. Announces Strategic Acquisition of Evergr - GuruFocus.com

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus to Acquire Evergreen Theragnostics for $250 Million - MSN

Jan 29, 2025
pulisher
Jan 28, 2025

Items Tagged with 'Life Molecular Imaging Ltd.' - BioWorld Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus lights up market with $1.025B Evergreen buy - BioWorld Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics to Expand Radiopharmaceutical Capabilities - HIT Consultant

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to buy radiopharma CDMO Evergreen Theragnostics for $250M upfront - MM+M Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to acquire Evergreen Theragnostics - MSN

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics in $1B Deal - USA Herald

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus (NASDAQ:LNTH) Trading Down 5.5%Should You Sell? - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

4 Firms Look To Build $1B Sale Of Evergreen Theragnostics - Law360

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus is on a buying spree. Its latest deal is worth up to $1B - The Business Journals

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus lights up market with up to $1B Evergreen buy - BioWorld Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio - Benzinga

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus Holdings to Acquire Evergreen Theragnostics - Contract Pharma

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment - GuruFocus.com

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus Holdings to Acquire Evergreen Theragnostics in All-Cash Transaction -January 28, 2025 at 06:52 am EST - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - PR Newswire

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront - GlobeNewswire

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive ... - The Bakersfield Californian

Jan 28, 2025
pulisher
Jan 28, 2025

Major Radiopharmaceutical Deal: Lantheus's $1B Game-Changing Move Into Cancer Treatment Manufacturing - StockTitan

Jan 28, 2025

Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$11.30
price down icon 0.66%
$31.91
price up icon 3.34%
$116.56
price down icon 1.90%
$10.54
price down icon 0.52%
$127.83
price up icon 0.14%
Capitalizzazione:     |  Volume (24 ore):